Investigación / Grupos de investigación

Grupo  29

Farmacología y Fisiopatología Vascular

Director/a
Francisco Perez Vizcaino
Tipo de grupo
CONSOLIDADO
Líneas de investigación

Axis 1. Pulmonary Hypertension

L1: Pulmonary vascular dysfunction in pulmonary hypertension (PH).

L2: Role of vitamin D and the microbiota in pulmonary hypertension (PH).

L3: Role of TASK1 and Kv7 potassium channels in pulmonary hypertension.

L4: Role of mutations in the KCNA5 gene in pulmonary hypertension patients.

L5: Liver-lung axis. How liver exosomes from healthy and cirrhotic animals influence the lung.

Axis 2. Erectile dysfunction

L1: Role of vitamin D and microbiota in erectile dysfunction.

Axis 3. Acute lung damage

L1: Acute Respiratory Distress Syndrome (ARDS).

L2: Bronchodysplasia of the lung (BDP).